<?xml version="1.0" encoding="UTF-8" ?> 

<rss version="2.0"> 
<channel> 
<title>Antimicrobials News</title> 
<link>http://www.mdlinx.com/pharmacy/news.cfm/newspage/1/spec_id/24/subspec_id/580</link> 
<description>Antimicrobials</description> 
<language>en-us</language> 
<copyright>Copyright 2013 MDLinx, Inc.</copyright>



<item> 
<title><![CDATA[Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant acinetobacter baumannii: a multicenter, randomized clinical trial]]></title> 
<link>http://www.mdlinx.com/pharmacy/news-article.cfm/4637213/?xml</link> 
<pubDate>5/22/2013</pubDate> 
<description><![CDATA[<b>Clinical Infectious Diseases</b>]]></description> 
<guid>http://www.mdlinx.com/pharmacy/news-article.cfm/4637213/?xml</guid>
</item> 

<item> 
<title><![CDATA[Relationship between weight, efavirenz exposure, and virologic suppression in HIV-infected patients on rifampin-based tuberculosis treatment in the AIDS clinical trials group A5221 STRIDE study]]></title> 
<link>http://www.mdlinx.com/pharmacy/news-article.cfm/4637214/?xml</link> 
<pubDate>5/22/2013</pubDate> 
<description><![CDATA[<b>Clinical Infectious Diseases</b>]]></description> 
<guid>http://www.mdlinx.com/pharmacy/news-article.cfm/4637214/?xml</guid>
</item> 

<item> 
<title><![CDATA[Evidence of improving antiretroviral therapy treatment delays: an analysis of eight years of programmatic outcomes in Blantyre, Malawi]]></title> 
<link>http://www.mdlinx.com/pharmacy/news-article.cfm/4636909/?xml</link> 
<pubDate>5/22/2013</pubDate> 
<description><![CDATA[<b>BMC Public Health</b>]]></description> 
<guid>http://www.mdlinx.com/pharmacy/news-article.cfm/4636909/?xml</guid>
</item> 

<item> 
<title><![CDATA[Deep sequencing reveals mutagenic effects of ribavirin during monotherapy of hepatitis C virus genotype 1-infected patients]]></title> 
<link>http://www.mdlinx.com/pharmacy/news-article.cfm/4610653/?xml</link> 
<pubDate>5/22/2013</pubDate> 
<description><![CDATA[<b>Journal of Virology</b>]]></description> 
<guid>http://www.mdlinx.com/pharmacy/news-article.cfm/4610653/?xml</guid>
</item> 

<item> 
<title><![CDATA[Impact of primary elvitegravir resistance-associated mutations in hiv-1 integrase on drug susceptibility and viral replication fitness ]]></title> 
<link>http://www.mdlinx.com/pharmacy/news-article.cfm/4622196/?xml</link> 
<pubDate>5/22/2013</pubDate> 
<description><![CDATA[<b>Antimicrobial Agents and Chemotherapy</b>]]></description> 
<guid>http://www.mdlinx.com/pharmacy/news-article.cfm/4622196/?xml</guid>
</item> 

<item> 
<title><![CDATA[Antimicrobial resistance and antimicrobial use associated with laboratory-confirmed cases of Campylobacter in two health units in Ontario]]></title> 
<link>http://www.mdlinx.com/pharmacy/news-article.cfm/4636290/?xml</link> 
<pubDate>5/22/2013</pubDate> 
<description><![CDATA[<b>Canadian Journal of Infectious Diseases &#38; Medical Microbiology</b>]]></description> 
<guid>http://www.mdlinx.com/pharmacy/news-article.cfm/4636290/?xml</guid>
</item> 

<item> 
<title><![CDATA[Update on rilpivirine: A new potent non-nucleoside reverse transcriptase inhibitor (NNRTI) of HIV replication]]></title> 
<link>http://www.mdlinx.com/pharmacy/news-article.cfm/4631348/?xml</link> 
<pubDate>5/22/2013</pubDate> 
<description><![CDATA[<b>Annals of Medicine</b>]]></description> 
<guid>http://www.mdlinx.com/pharmacy/news-article.cfm/4631348/?xml</guid>
</item> 

<item> 
<title><![CDATA[Antibiotic resistance and expression of resistance-nodulation-division pumps and outer membrane porins in Acinetobacter species isolated from Canadian hospitals]]></title> 
<link>http://www.mdlinx.com/pharmacy/news-article.cfm/4636280/?xml</link> 
<pubDate>5/22/2013</pubDate> 
<description><![CDATA[<b>Canadian Journal of Infectious Diseases &#38; Medical Microbiology</b>]]></description> 
<guid>http://www.mdlinx.com/pharmacy/news-article.cfm/4636280/?xml</guid>
</item> 

<item> 
<title><![CDATA[Augmented renal clearance is a common finding with worse clinical outcome in critically ill patients receiving antimicrobial therapy]]></title> 
<link>http://www.mdlinx.com/pharmacy/news-article.cfm/4628162/?xml</link> 
<pubDate>5/22/2013</pubDate> 
<description><![CDATA[<b>Journal of Critical Care</b>]]></description> 
<guid>http://www.mdlinx.com/pharmacy/news-article.cfm/4628162/?xml</guid>
</item> 

<item> 
<title><![CDATA[Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients]]></title> 
<link>http://www.mdlinx.com/pharmacy/news-article.cfm/4635759/?xml</link> 
<pubDate>5/22/2013</pubDate> 
<description><![CDATA[<b>Transplant Infectious Disease</b>]]></description> 
<guid>http://www.mdlinx.com/pharmacy/news-article.cfm/4635759/?xml</guid>
</item> 

<item> 
<title><![CDATA[The antibiotic resistance and prescribing in european children project: a neonatal and pediatric antimicrobial web-based point prevalence survey in 73 hospitals worldwide]]></title> 
<link>http://www.mdlinx.com/pharmacy/news-article.cfm/4629671/?xml</link> 
<pubDate>5/22/2013</pubDate> 
<description><![CDATA[<b>The Pediatric Infectious Disease Journal</b>]]></description> 
<guid>http://www.mdlinx.com/pharmacy/news-article.cfm/4629671/?xml</guid>
</item> 
  


</channel> 
</rss>

